vs
Side-by-side financial comparison of GE HealthCare (GEHC) and QVC Group, Inc. (QVCGA). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.1B vs $2.7B, roughly 1.9× QVC Group, Inc.). GE HealthCare runs the higher net margin — 8.0% vs -1.4%, a 9.4% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.4% vs -9.1%). QVC Group, Inc. produced more free cash flow last quarter ($191.0M vs $112.0M). Over the past eight quarters, QVC Group, Inc.'s revenue compounded faster (6.9% CAGR vs 3.0%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
QVC Group, is an American media conglomerate controlled by company chairman John C. Malone, who owns a majority of the voting shares.
GEHC vs QVCGA — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.1B | $2.7B |
| Net Profit | $411.0M | $-37.0M |
| Gross Margin | 38.5% | 32.9% |
| Operating Margin | 10.0% | 3.7% |
| Net Margin | 8.0% | -1.4% |
| Revenue YoY | 7.4% | -9.1% |
| Net Profit YoY | -31.0% | 97.1% |
| EPS (diluted) | $0.85 | $-17.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $5.1B | — | ||
| Q4 25 | $5.7B | $2.7B | ||
| Q3 25 | $5.1B | $2.2B | ||
| Q2 25 | $5.0B | $2.2B | ||
| Q1 25 | $4.8B | $2.1B | ||
| Q4 24 | $5.3B | $2.9B | ||
| Q3 24 | $4.9B | $2.3B | ||
| Q2 24 | $4.8B | $2.4B |
| Q1 26 | $411.0M | — | ||
| Q4 25 | $588.0M | $-37.0M | ||
| Q3 25 | $446.0M | $-80.0M | ||
| Q2 25 | $486.0M | $-2.2B | ||
| Q1 25 | $564.0M | $-100.0M | ||
| Q4 24 | $721.0M | $-1.3B | ||
| Q3 24 | $470.0M | $-23.0M | ||
| Q2 24 | $428.0M | $20.0M |
| Q1 26 | 38.5% | — | ||
| Q4 25 | 39.7% | 32.9% | ||
| Q3 25 | 38.7% | 34.0% | ||
| Q2 25 | 39.6% | 36.4% | ||
| Q1 25 | 42.1% | 34.2% | ||
| Q4 24 | 42.8% | 33.3% | ||
| Q3 24 | 41.7% | 35.3% | ||
| Q2 24 | 41.4% | 36.4% |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 14.5% | 3.7% | ||
| Q3 25 | 12.7% | 2.7% | ||
| Q2 25 | 13.1% | -101.6% | ||
| Q1 25 | 13.2% | 0.7% | ||
| Q4 24 | 15.1% | -43.2% | ||
| Q3 24 | 13.9% | 6.5% | ||
| Q2 24 | 12.6% | 6.9% |
| Q1 26 | 8.0% | — | ||
| Q4 25 | 10.3% | -1.4% | ||
| Q3 25 | 8.7% | -3.6% | ||
| Q2 25 | 9.7% | -99.4% | ||
| Q1 25 | 11.8% | -4.8% | ||
| Q4 24 | 13.6% | -43.7% | ||
| Q3 24 | 9.7% | -1.0% | ||
| Q2 24 | 8.8% | 0.8% |
| Q1 26 | $0.85 | — | ||
| Q4 25 | $1.28 | $-17.37 | ||
| Q3 25 | $0.98 | $-9.89 | ||
| Q2 25 | $1.06 | $-275.46 | ||
| Q1 25 | $1.23 | $-0.25 | ||
| Q4 24 | $1.58 | — | ||
| Q3 24 | $1.02 | $-0.06 | ||
| Q2 24 | $0.93 | $2.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $2.0B |
| Total DebtLower is stronger | $10.1B | $790.0M |
| Stockholders' EquityBook value | $10.7B | $-3.1B |
| Total Assets | $37.1B | $7.6B |
| Debt / EquityLower = less leverage | 0.95× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.5B | $2.0B | ||
| Q3 25 | $4.0B | $1.8B | ||
| Q2 25 | $3.7B | $897.0M | ||
| Q1 25 | $2.5B | $833.0M | ||
| Q4 24 | $2.9B | $905.0M | ||
| Q3 24 | $3.5B | $873.0M | ||
| Q2 24 | $2.0B | $1.2B |
| Q1 26 | $10.1B | — | ||
| Q4 25 | $10.0B | $790.0M | ||
| Q3 25 | $10.3B | $5.9B | ||
| Q2 25 | $10.3B | $4.9B | ||
| Q1 25 | $8.8B | $5.0B | ||
| Q4 24 | $9.0B | $4.1B | ||
| Q3 24 | $10.3B | $5.1B | ||
| Q2 24 | $9.2B | $5.3B |
| Q1 26 | $10.7B | — | ||
| Q4 25 | $10.4B | $-3.1B | ||
| Q3 25 | $10.0B | $-3.1B | ||
| Q2 25 | $9.7B | $-3.0B | ||
| Q1 25 | $9.2B | $-981.0M | ||
| Q4 24 | $8.4B | $-971.0M | ||
| Q3 24 | $8.3B | $397.0M | ||
| Q2 24 | $7.8B | $328.0M |
| Q1 26 | $37.1B | — | ||
| Q4 25 | $36.9B | $7.6B | ||
| Q3 25 | $36.1B | $7.6B | ||
| Q2 25 | $35.5B | $6.7B | ||
| Q1 25 | $33.6B | $9.0B | ||
| Q4 24 | $33.1B | $9.2B | ||
| Q3 24 | $33.9B | $10.8B | ||
| Q2 24 | $31.9B | $10.9B |
| Q1 26 | 0.95× | — | ||
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 1.24× | 12.74× | ||
| Q2 24 | 1.18× | 16.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $244.0M |
| Free Cash FlowOCF − Capex | $112.0M | $191.0M |
| FCF MarginFCF / Revenue | 2.2% | 7.1% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $118.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $244.0M | ||
| Q3 25 | — | $4.0M | ||
| Q2 25 | $94.0M | $86.0M | ||
| Q1 25 | $250.0M | $-60.0M | ||
| Q4 24 | — | $212.0M | ||
| Q3 24 | — | $20.0M | ||
| Q2 24 | $-119.0M | $267.0M |
| Q1 26 | $112.0M | — | ||
| Q4 25 | — | $191.0M | ||
| Q3 25 | — | $-27.0M | ||
| Q2 25 | $8.0M | $48.0M | ||
| Q1 25 | $98.0M | $-94.0M | ||
| Q4 24 | — | $150.0M | ||
| Q3 24 | — | $-23.0M | ||
| Q2 24 | $-183.0M | $213.0M |
| Q1 26 | 2.2% | — | ||
| Q4 25 | — | 7.1% | ||
| Q3 25 | — | -1.2% | ||
| Q2 25 | 0.2% | 2.1% | ||
| Q1 25 | 2.1% | -4.5% | ||
| Q4 24 | — | 5.1% | ||
| Q3 24 | — | -1.0% | ||
| Q2 24 | -3.8% | 8.8% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 2.0% | ||
| Q3 25 | 2.1% | 1.4% | ||
| Q2 25 | 1.7% | 1.7% | ||
| Q1 25 | 3.2% | 1.6% | ||
| Q4 24 | 1.9% | 2.1% | ||
| Q3 24 | 1.9% | 1.8% | ||
| Q2 24 | 1.3% | 2.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.44× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.28× | 13.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
QVCGA
| Other | $915.0M | 34% |
| Home | $754.0M | 28% |
| Beauty | $260.0M | 10% |
| Apparel | $254.0M | 9% |
| Electronics | $187.0M | 7% |
| Accessories | $181.0M | 7% |
| Jewelry | $87.0M | 3% |
| Manufactured Product Other | $38.0M | 1% |
